InTRIMsic immunity: Positive and negative regulation of immune signaling by tripartite motif proteins

Cytokine and Growth Factor Reviews

Volumn 25, Issue 5, 2014, Pages 563-576

  Versteeg, Gijs A ^a   Benke, Stefan ^a   García Sastre, Adolfo ^b   Rajsbaum, Ricardo ^b,c  

^a UNIVERSITY OF VIENNA   (Austria)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

E3 ligase; Interferon; TRIM protein; TRIMmunity; Ubiquitin

Indexed keywords

BETA INTERFERON; INFLAMMASOME; PATTERN RECOGNITION RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR; TRIPARTITE MOTIF PROTEIN; TRIPARTITE MOTIF PROTEIN 14; TRIPARTITE MOTIF PROTEIN 19; TRIPARTITE MOTIF PROTEIN 21; TRIPARTITE MOTIF PROTEIN 23; TRIPARTITE MOTIF PROTEIN 30; TRIPARTITE MOTIF PROTEIN 5; TRIPARTITE MOTIF PROTEIN 6; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; CYTOKINE; MEMBRANE PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRIM PROTEIN, HUMAN;

BACTERIAL INFECTION; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DENDRITIC CELL; HOST RESISTANCE; HUMAN; IMMUNITY; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; INTERFERON PRODUCTION; MACROPHAGE; NONHUMAN; PROTEIN DEGRADATION; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UBIQUITINATION; VIRUS INFECTION; ANIMAL; CLASSIFICATION; IMMUNOLOGY; INVERTEBRATE; MOLECULAR EVOLUTION; PROTEIN MOTIF;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID MOTIFS; ANIMALS; CYTOKINES; EVOLUTION, MOLECULAR; HUMANS; IMMUNITY, INNATE; INVERTEBRATES; MEMBRANE PROTEINS; SIGNAL TRANSDUCTION; UBIQUITIN;

EID: 84908267694     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2014.08.001     Document Type: Short Survey

References (127)

1. Latz E., Xiao T.S., Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol 2013, 13:397-411.
2. Ivashkiv L.B., Donlin L.T. Regulation of type I interferon responses. Nat Rev Immunol 2014, 14:36-49.
3. González-Navajas J.M., Lee J., David M., Raz E. Immunomodulatory functions of type I interferons. Nat Rev Immunol 2012, 12:125-135.
4. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
5. Versteeg G.A., Garcia-Sastre A. Viral tricks to grid-lock the type I interferon system. Curr Opin Microbiol 2010, 13:508-516.
6. Ganguly D., Haak S., Sisirak V., Reizis B. The role of dendritic cells in autoimmunity. Nat Rev Immunol 2013, 13:566-577.
7. Jefferies C., Wynne C., Higgs R. Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease. Nat Rev Immunol 2011, 11:617-625.
8. Liu S., Chen Z.J. Expanding role of ubiquitination in NF-kappaB signaling. Cell Res 2011, 21:6-21.
9. Husnjak K., Dikic I. Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions. Ann Rev Biochem 2012, 81:291-322.
10. Metzger M.B., Hristova V.A., Weissman A.M. HECT and RING finger families of E3 ubiquitin ligases at a glance. J Cell Sci 2012, 125:531-537.
11. Hicke L., Schubert H.L., Hill C.P. Ubiquitin-binding domains. Nat Rev Mol Cell Biol 2005, 6:610-621.
12. Rajsbaum R., Garcia-Sastre A. Viral evasion mechanisms of early antiviral responses involving regulation of ubiquitin pathways. Trends Microbiol 2013, 21:421-429.
13. Pertel T., Hausmann S., Morger D., Zuger S., Guerra J., Lascano J., et al. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 2011, 472:361-365.
14. Rajsbaum R., Versteeg G.A., Schmid S., Maestre A.M., Belicha-Villanueva A., Martinez-Romero C., et al. Unanchored K48-linked polyubiquitin synthesized by the E3-ubiquitin ligase TRIM6 stimulates the interferon-IKK epsilon kinase-mediated antiviral response. Immunity 2014, 40:880-895.
15. Zeng W., Sun L., Jiang X., Chen X., Hou F., Adhikari A., et al. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 2010, 141:315-330.
16. Zou W., Zhang D.E. The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase. J Biol Chem 2006, 281:3989-3994.
17. Amir R.E., Iwai K., Ciechanover A. The NEDD8 pathway is essential for SCFβ-TrCP-mediated ubiquitination and processing of the NF-κB precursor p105. J Biol Chem 2002, 277:23253-23259.
18. Arimoto K., Konishi H., Shimotohno K. UbcH8 regulates ubiquitin and ISG15 conjugation to RIG-I. Mol Immunol 2008, 45:1078-1084.
19. Begitt A., Droescher M., Knobeloch K.P., Vinkemeier U. SUMO conjugation of STAT1 protects cells from hyperresponsiveness to IFNgamma. Blood 2011, 118:1002-1007.
20. Kim M.J., Hwang S.Y., Imaizumi T., Yoo J.Y. Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J Virol 2008, 82:1474-1483.
21. Regad T., Chelbi-Alix M.K. Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene 2001, 20:7274-7286.
22. Vatsyayan J., Qing G., Xiao G., Hu J. SUMO1 modification of NF-kappaB2/p100 is essential for stimuli-induced p100 phosphorylation and processing. EMBO Rep 2008, 9:885-890.
23. Jones J., Wu K., Yang Y., Guerrero C., Nillegoda N., Pan Z.Q., et al. A targeted proteomic analysis of the ubiquitin-like modifier nedd8 and associated proteins. J Proteome Res 2008, 7:1274-1287.
24. Srikumar T., Lewicki M.C., Costanzo M., Tkach J.M., van Bakel H., Tsui K., et al. Global analysis of SUMO chain function reveals multiple roles in chromatin regulation. J Cell Biol 2013, 201:145-163.
25. Xirodimas D.P., Sundqvist A., Nakamura A., Shen L., Botting C., Hay R.T. Ribosomal proteins are targets for the NEDD8 pathway. EMBO Rep 2008, 9:280-286.
26. Rajsbaum R., Stoye J.P., O'Garra A. Type I interferon-dependent and -independent expression of tripartite motif proteins in immune cells. Eur J Immunol 2008, 38:619-630.
27. Uchil P.D., Hinz A., Siegel S., Coenen-Stass A., Pertel T., Luban J., et al. TRIM protein mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activity. J Virol 2013, 87:257-272.
28. Versteeg G.A., Rajsbaum R., Sanchez-Aparicio M.T., Maestre A.M., Valdiviezo J., Shi M., et al. The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors. Immunity 2013, 38:384-398.
29. Carthagena L., Bergamaschi A., Luna J.M., David A., Uchil P.D., Margottin-Goguet F., et al. Human TRIM gene expression in response to interferons. PLoS ONE 2009, 4:e4894.
30. Demuth J.P., De Bie T., Stajich J.E., Cristianini N., Hahn M.W. The evolution of mammalian gene families. PLoS ONE 2006, 1:e85.
31. Lukic Z., Hausmann S., Sebastian S., Rucci J., Sastri J., Robia S.L., et al. TRIM5alpha associates with proteasomal subunits in cells while in complex with HIV-1 virions. Retrovirology 2011, 8:93.
32. Stremlau M., Perron M., Lee M., Li Y., Song B., Javanbakht H., et al. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc Natl Acad Sci U S A 2006, 103:5514-5519.
33. Roa A., Hayashi F., Yang Y., Lienlaf M., Zhou J., Shi J., et al. RING domain mutations uncouple TRIM5alpha restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoating. J Virol 2012, 86:1717-1727.
34. Kutluay S.B., Perez-Caballero D., Bieniasz P.D. Fates of retroviral core components during unrestricted and TRIM5-restricted infection. PLoS Pathog 2013, 9:e1003214.
35. Yap M.W., Nisole S., Lynch C., Stoye J.P. Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc Natl Acad Sci U S A 2004, 101:10786-10791.
36. Sayah D.M., Sokolskaja E., Berthoux L., Luban J., Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 2004, 430:569-573.
37. Wilson S.J., Webb B.L., Ylinen L.M., Verschoor E., Heeney J.L., Towers G.J. Independent evolution of an antiviral TRIMCyp in rhesus macaques. Proc Natl Acad Sci U S A 2008, 105:3557-3562.
38. Nisole S., Stoye J.P., Saib A. TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol 2005, 3:799-808.
39. Rajsbaum R., Garcia-Sastre A., Versteeg G.A. TRIMmunity: the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity. J Mol Biol 2014, 426:1265-1284.
40. Massiah M.A., Matts J.A., Short K.M., Simmons B.N., Singireddy S., Yi Z., et al. Solution structure of the MID1 B-box2 CHC(D/C)C(2)H(2) zinc-binding domain: insights into an evolutionarily conserved RING fold. J Mol Biol 2007, 369:1-10.
41. Short K.M., Cox T.C. Subclassification of the RBCC/TRIM superfamily reveals a novel motif necessary for microtubule binding. J Biol Chem 2006, 281:8970-8980.
42. Bell J.L., Malyukova A., Holien J.K., Koach J., Parker M.W., Kavallaris M., et al. TRIM16 acts as an E3 ubiquitin ligase and can heterodimerize with other TRIM family members. PLoS ONE 2012, 7:e37470.
43. Yu J.W., Fernandes-Alnemri T., Datta P., Wu J., Juliana C., Solorzano L., et al. Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants. Mol Cell 2007, 28:214-227.
44. Zhou Z., Jia X., Xue Q., Dou Z., Ma Y., Zhao Z., et al. TRIM14 is a mitochondrial adaptor that facilitates retinoic acid-inducible gene-I-like receptor-mediated innate immune response. Proc Natl Acad Sci U S A 2014, 111:E245-E254.
45. Reymond A., Meroni G., Fantozzi A., Merla G., Cairo S., Luzi L., et al. The tripartite motif family identifies cell compartments. EMBO J 2001, 20:2140-2151.
46. Cainarca S., Messali S., Ballabio A., Meroni G. Functional characterization of the Opitz syndrome gene product (midin): evidence for homodimerization and association with microtubules throughout the cell cycle. Hum Mol Genet 1999, 8:1387-1396.
47. Cao T., Borden K.L., Freemont P.S., Etkin L.D. Involvement of the rfp tripartite motif in protein-protein interactions and subcellular distribution. J Cell Sci 1997, 110(Pt 14):1563-1571.
48. Napolitano L.M., Meroni G. TRIM family: pleiotropy and diversification through homomultimer and heteromultimer formation. IUBMB Life 2012, 64:64-71.
49. Yap M.W., Nisole S., Stoye J.P. A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction. Curr Biol 2005, 15:73-78.
50. Meroni G. Genomics and evolution of the TRIM gene family. Adv Exp Med Biol 2012, 770:1-9.
51. Boudinot P., van der Aa L.M., Jouneau L., Du Pasquier L., Pontarotti P., Briolat V., et al. Origin and evolution of TRIM proteins: new insights from the complete TRIM repertoire of zebrafish and pufferfish. PLoS ONE 2011, 6:e22022.
52. van der Aa L.M., Levraud J.P., Yahmi M., Lauret E., Briolat V., Herbomel P., et al. A large new subset of TRIM genes highly diversified by duplication and positive selection in teleost fish. BMC Biol 2009, 7:7.
53. Sardiello M., Cairo S., Fontanella B., Ballabio A., Meroni G. Genomic analysis of the TRIM family reveals two groups of genes with distinct evolutionary properties. BMC Evol Biol 2008, 8:225.
54. Flajnik M.F., Du Pasquier L. Evolution of innate and adaptive immunity: can we draw a line. Trends Immunol 2004, 25:640-644.
55. Nehyba J., Hrdlickova R., Bose H.R. Dynamic evolution of immune system regulators: the history of the interferon regulatory factor family. Mol Biol Evol 2009, 26:2539-2550.
56. Xu L., Yang L., Liu W. Distinct evolution process among type I interferon in mammals. Protein Cell 2013, 4:383-392.
57. Langevin C., Aleksejeva E., Passoni G., Palha N., Levraud J-P., Boudinot P. The antiviral innate immune response in fish: evolution and conservation of the IFN system. J Mol Biol 2013, 425:4904-4920.
58. Hickford D., Frankenberg S., Shaw G., Renfree M.B. Evolution of vertebrate interferon inducible transmembrane proteins. BMC Genom 2012, 13:155.
59. Kumar S., Mitnik C., Valente G., Floyd-Smith G. Expansion and molecular evolution of the interferon-induced 2'-5' oligoadenylate synthetase gene family. Mol Biol Evol 2000, 17:738-750.
60. Reboul J., Gardiner K., Monneron D., Uze G., Lutfalla G. Comparative genomic analysis of the interferon/interleukin-10 receptor gene cluster. Genome Res 1999, 9:242-250.
61. Manry J., Laval G., Patin E., Fornarino S., Itan Y., Fumagalli M., et al. Evolutionary genetic dissection of human interferons. J Exp Med 2011, 208:2747-2759.
62. Cai X., Srivastava S., Sun Y., Li Z., Wu H., Zuvela-Jelaska L., et al. Tripartite motif containing protein 27 negatively regulates CD4 T cells by ubiquitinating and inhibiting the class II PI3K-C2beta. Proc Natl Acad Sci U S A 2011, 108:20072-20077.
63. Chikuma S., Suita N., Okazaki I.M., Shibayama S., Honjo T. TRIM28 prevents autoinflammatory T cell development in vivo. Nat Immunol 2012, 13:596-603.
64. Rajsbaum R., Albrecht R.A., Wang M.K., Maharaj N.P., Versteeg G.A., Nistal-Villan E., et al. Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein. PLoS Pathog 2012, 8:e1003059.
65. Han K., Lou D.I., Sawyer S.L. Identification of a genomic reservoir for new TRIM genes in primate genomes. PLoS Genet 2011, 7:e1002388.
66. Ichimura T., Taoka M., Shoji I., Kato H., Sato T., Hatakeyama S., et al. 14-3-3 proteins sequester a pool of soluble TRIM32 ubiquitin ligase to repress autoubiquitylation and cytoplasmic body formation. J Cell Sci 2013, 126:2014-2026.
67. Fensterl V., Wetzel J.L., Ramachandran S., Ogino T., Stohlman S.A., Bergmann C.C., et al. Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. PLoS Pathog 2012, 8:e1002712.
68. Mancuso G., Midiri A., Biondo C., Beninati C., Zummo S., Galbo R., et al. Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria. J Immunol 2007, 178:3126-3133.
69. Robinson N., McComb S., Mulligan R., Dudani R., Krishnan L., Sad S. Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium. Nat Immunol 2012, 13:954-962.
70. Li M., Liu X., Zhou Y., Su S.B. Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses. J Leukoc Biol 2009, 86:23-32.
71. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007, 87:245-313.
72. Kuhns D.B., Alvord W.G., Heller T., Feld J.J., Pike K.M., Marciano B.E., et al. Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 2010, 363:2600-2610.
73. Keeble A.H., Khan Z., Forster A., James L.C. TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved. Proc Natl Acad Sci U S A 2008, 105:6045-6050.
74. McEwan W.A., Tam J.C., Watkinson R.E., Bidgood S.R., Mallery D.L., James L.C. Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21. Nat Immunol 2013, 14:327-336.
75. Vaysburd M., Watkinson R.E., Cooper H., Reed M., O'Connell K., Smith J., et al. Intracellular antibody receptor TRIM21 prevents fatal viral infection. Proc Natl Acad Sci U S A 2013, 110:12397-12401.
76. Gack M.U., Shin Y.C., Joo C.H., Urano T., Liang C., Sun L., et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007, 446:916-920.
77. Hornung V., Ellegast J., Kim S., Brzozka K., Jung A., Kato H., et al. 5'-Triphosphate RNA is the ligand for RIG-I. Science 2006, 314:994-997.
78. Kato H., Takeuchi O., Mikamo-Satoh E., Hirai R., Kawai T., Matsushita K., et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 2008, 205:1601-1610.
79. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441:101-105.
80. Runge S., Sparrer K.M.J., Lässig C., Hembach K., Baum A., García-Sastre A., et al. In vivo ligands of MDA5 and RIG-I in measles virus-infected cells. PLoS Pathog 2014, 10:e1004081.
81. Hou F., Sun L., Zheng H., Skaug B., Jiang Q.X., Chen Z.J. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 2011, 146:448-461.
82. Seth R.B., Sun L., Ea C.K., Chen Z.J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005, 122:669-682.
83. Peisley A., Wu B., Xu H., Chen Z.J., Hur S. Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I. Nature 2014, 509:110-114.
84. Wu B., Peisley A., Richards C., Yao H., Zeng X., Lin C., et al. Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell 2013, 152:276-289.
85. Jiang X., Kinch L.N., Brautigam C.A., Chen X., Du F., Grishin N.V., et al. Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response. Immunity 2012, 36:959-973.
86. Oshiumi H., Miyashita M., Inoue N., Okabe M., Matsumoto M., Seya T. The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection. Cell Host Microbe 2010, 8:496-509.
87. Yan J., Li Q., Mao A.P., Hu M.M., Shu H.B. TRIM4 modulates type I interferon induction and cellular antiviral response by targeting RIG-I for K63-linked ubiquitination. J Mol Cell Biol 2014, 6:154-163.
88. Hornung V., Ablasser A., Charrel-Dennis M., Bauernfeind F., Horvath G., Caffrey D.R., et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009, 458:514-518.
89. Zhang Z., Yuan B., Bao M., Lu N., Kim T., Liu Y-J. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat Immunol 2011, 12:959-965.
90. Parvatiyar K., Zhang Z., Teles R.M., Ouyang S., Jiang Y., Iyer S.S., et al. The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response. Nat Immunol 2012, 13:1155-1161.
91. Zhang Z., Bao M., Lu N., Weng L., Yuan B., Liu Y.J. The E3 ubiquitin ligase TRIM21 negatively regulates the innate immune response to intracellular double-stranded DNA. Nat Immunol 2013, 14:172-178.
92. Zurek B., Schoultz I., Neerincx A., Napolitano L.M., Birkner K., Bennek E., et al. TRIM27 negatively regulates NOD2 by ubiquitination and proteasomal degradation. PLoS ONE 2012, 7:e41255.
93. Yang B., Wang J., Wang Y., Zhou H., Wu X., Tian Z., et al. Novel function of Trim44 promotes an antiviral response by stabilizing VISA. J Immunol 2013, 190:3613-3619.
94. Zhang J., Hu M.M., Wang Y.Y., Shu H.B. TRIM32 protein modulates type I interferon induction and cellular antiviral response by targeting MITA/STING protein for K63-linked ubiquitination. J Biol Chem 2012, 287:28646-28655.
95. Tsuchida T., Zou J., Saitoh T., Kumar H., Abe T., Matsuura Y., et al. The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA. Immunity 2010, 33:765-776.
96. Xie P. TRAF molecules in cell signaling and in human diseases. J Mol Signal 2013, 8:7.
97. Kanayama A., Seth R.B., Sun L., Ea C-K., Hong M., Shaito A., et al. TAB2 and TAB3 activate the NF-κB pathway through binding to polyubiquitin chains. Mol Cell 2004, 15:535-548.
98. Zhao W., Wang L., Zhang M., Yuan C., Gao C. E3 ubiquitin ligase tripartite motif 38 negatively regulates TLR-mediated immune responses by proteasomal degradation of TNF receptor-associated factor 6 in macrophages. J Immunol 2012, 188:2567-2574.
99. Liu S., Chen J., Cai X., Wu J., Chen X., Wu Y.T., et al. MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades. eLife 2013, 2:e00785.
100. Shi M., Deng W., Bi E., Mao K., Ji Y., Lin G., et al. TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation. Nat Immunol 2008, 9:369-377.
101. Choi U.Y., Hur J.Y., Lee M.S., Zhang Q., Choi W.Y., Kim L.K., et al. Tripartite motif-containing protein 30 modulates TCR-activated proliferation and effector functions in CD4+ T cells. PLoS ONE 2014, 9:e95805.
102. Chau T.-L., Gioia R., Gatot J.-S., Patrascu F., Carpentier I., Chapelle J.-P., et al. Are the IKKs and IKK-related kinases TBK1 and IKK-e similarly activated?. Trends Biochem Sci 2008, 33:171-180.
103. Zhao W., Wang L., Zhang M., Wang P., Yuan C., Qi J., et al. Tripartite motif-containing protein 38 negatively regulates TLR3/4- and RIG-I-mediated IFN-beta production and antiviral response by targeting NAP1. J Immunol 2012, 188:5311-5318.
104. Hu M.M., Yang Q., Zhang J., Liu S.M., Zhang Y., Lin H., et al. TRIM38 inhibits TNFalpha- and IL-1beta-triggered NF-kappaB activation by mediating lysosome-dependent degradation of TAB2/3. Proc Natl Acad Sci U S A 2014, 111:1509-1514.
105. Arimoto K., Funami K., Saeki Y., Tanaka K., Okawa K., Takeuchi O., et al. Polyubiquitin conjugation to NEMO by triparite motif protein 23 (TRIM23) is critical in antiviral defense. Proc Natl Acad Sci U S A 2010, 107:15856-15861.
106. Platanias L.C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 2005, 5:375-386.
107. Tenoever B.R., Ng S.L., Chua M.A., McWhirter S.M., Garcia-Sastre A., Maniatis T. Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science 2007, 315:1274-1278.
108. Ng S.L., Friedman B.A., Schmid S., Gertz J., Myers R.M., Tenoever B.R., et al. IkappaB kinase epsilon (IKK(epsilon)) regulates the balance between type I and type II interferon responses. Proc Natl Acad Sci U S A 2011, 108:21170-21175.
109. Yang K., Shi H.X., Liu X.Y., Shan Y.F., Wei B., Chen S., et al. TRIM21 is essential to sustain IFN regulatory factor 3 activation during antiviral response. J Immunol 2009, 182:3782-3792.
110. Higgs R., Gabhann J.N., Larbi N.B., Breen E.P., Fitzgerald K.A., Jefferies C.A. The E3 ubiquitin ligase Ro52 negatively regulates IFN-β production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3. J Immunol 2008, 181:1780-1786.
111. Higgs R., Lazzari E., Wynne C., Ni Gabhann J., Espinosa A., Wahren-Herlenius M., et al. Self protection from anti-viral responses - Ro52 promotes degradation of the transcription factor IRF7 downstream of the viral Toll-Like receptors. PLoS ONE 2010, 5:e11776.
112. Espinosa A., Dardalhon V., Brauner S., Ambrosi A., Higgs R., Quintana F.J., et al. Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. J Exp Med 2009, 206:1661-1671.
113. Ozato K., Yoshimi R., Chang T-H., Wang H., Atsumi T., Morse H.C. Comment on gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-κB-dependent cytokine expression in fibroblasts. J Immunol 2009, 183:7619.
114. Yoshimi R., Chang T.H., Wang H., Atsumi T., Morse H.C., Ozato K. Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-kappaB-dependent cytokine expression in fibroblasts. J Immunol 2009, 182:7527-7538.
115. Lamkanfi M., Dixit V.M. Mechanisms and functions of inflammasomes. Cell 2014, 157:1013-1022.
116. Latz E. The inflammasomes: mechanisms of activation and function. Curr Opin Immunol 2010, 22:28-33.
117. Hu Y., Mao K., Zeng Y., Chen S., Tao Z., Yang C., et al. Tripartite-motif protein 30 negatively regulates NLRP3 inflammasome activation by modulating reactive oxygen species production. J Immunol 2010, 185:7699-7705.
118. Chae J.J., Cho Y.H., Lee G.S., Cheng J., Liu P.P., Feigenbaum L., et al. Gain-of-function pyrin mutations induce NLRP3 protein-independent interleukin-1beta activation and severe autoinflammation in mice. Immunity 2011, 34:755-768.
119. Hesker P.R., Nguyen M., Kovarova M., Ting J.P.Y., Koller B.H. Genetic loss of murine pyrin, the familial Mediterranean fever protein, increases interleukin-1β levels. PLoS ONE 2012, 7:e51105.
120. Chae J.J., Centola M., Aksentijevich I., Dutra A., Tran M., Wood G., et al. Isolation, genomic organization, and expression analysis of the mouse and rat homologs of MEFV, the gene for familial Mediterranean fever. Mamm Genome 2000, 11:428-435.
121. Chae J.J., Wood G., Masters S.L., Richard K., Park G., Smith B.J., et al. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci U S A 2006, 103:9982-9987.
122. Chae J.J., Komarow H.D., Cheng J., Wood G., Raben N., Liu P.P., et al. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell 2003, 11:591-604.
123. Maarifi G., Chelbi-Alix M.K., Nisole S. PML control of cytokine signaling. Cytokine Growth Factor Rev 2014, 25:551-561.
124. El Asmi F., Maroui M.A., Dutrieux J., Blondel D., Nisole S., Chelbi-Alix M.K. Implication of PMLIV in both intrinsic and innate immunity. PLoS Pathog 2014, 10:e1003975.
125. Hatakeyama S. TRIM proteins and cancer. Nat Rev Cancer 2011, 11:792-804.
126. Ben-Neriah Y., Karin M. Inflammation meets cancer, with NF-[kappa]B as the matchmaker. Nat Immunol 2011, 12:715-723.
127. Kumar M.S., Hancock D.C., Molina-Arcas M., Steckel M., East P., Diefenbacher M., et al. The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer. Cell 2012, 149:642-655.